COSFROVIXIMAB

UNII: 820CI2BHRP
Preferred Substance Name: COSFROVIXIMAB

1792982-57-0
13C6
C13C6FR1
C13C6-FR1
COSFROVIXIMAB [INN]
COSFROVIXIMAB [USAN]
COSFROVIXIMAB [WHO-DD]
IMMUNOGLOBULIN G1, ANTI-(EBOLAVIRUS/RESTON EBOLAVIRUS/SUDAN EBOLAVIRUS/TAI FOREST EBOLAVIRUS GLYCOPROTEIN) (HUMAN-MUS MUSCULUS MONOCLONAL C13C6-FR1 HEAVY CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL C13C6-FR1 .KAPPA.-CHAIN, DIMER
MB-003 COMPONENT C13C6-FR1
ZMAPP COMPONENT C13C6
ZMAPP COMPONENT C13C6FR1
ZMAPP COMPONENT C13C6-FR1

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

About, Contact Us, Copyright, Privacy, Accessibility

U.S. Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD 20993-0002

U.S. Food and Drug Administration, Health & Human Services

Freedom of Information Act

COSFROVIXIMAB

Synonyms and Mappings

Resources

Note